Resumen de negocios
Número de empleados: 50
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ajay Sahni
CEO | Chief Executive Officer | 57 | 01/01/08 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 85 | 01/04/19 | |
Ajay Sahni
CEO | Chief Executive Officer | 57 | 01/01/08 |
Ravi Limaye
BRD | Director/Board Member | 60 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 51 948 000 | 51 428 520 ( 99,00 %) | 0 | 99,00 % |
Información de la empresa
![Dirección Wockhardt Bio AG(WBIO)](https://cdn.zonebourse.com/static/address/23454514.png)
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Laboratoires Negma SAS
![]() Laboratoires Negma SAS Pharmaceuticals: MajorHealth Technology Laboratoires Negma SAS manufactures pharmaceutical products. It has products in the osteoarthritis, anti-hemorrhoids, anti-hypertension, rheumatology, phlebotonic, and vesical instability. The company also has manufacturing facilities in Europe. Laboratoires Negma S.A.S. was formerly known as Negma Lerads S.A.S. the company was founded in 1996 and is headquartered in Velizy Villacoublay, France |
Pharmaceuticals: Major
|
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+20,05 % | 43,67 mil M | |
+26,21 % | 22,79 mil M | |
+20,73 % | 15,45 mil M | |
+18,43 % | 14,29 mil M | |
+53,47 % | 12,83 mil M | |
-0,05 % | 6787,61 M | |
-11,88 % | 6516,18 M | |
+12,62 % | 5587,79 M | |
-8,87 % | 5725,52 M |